Sandostatin Inj 0.05mg is primarily indicated in conditions like Acromegaly, Adjunct in ganciclovir treatment, Carcinoid tumours, Glucagonoma, Hormone-mediated secretory diarrhea, To reduce intestinal secretions and vomiting (palliative care), Variceal bleeding, Vipoma, and can also be given in adjunctive therapy as an alternative drug of choice in Acromegaly (short-term treatment before pituitary surgery), Hormone-mediated secretory diarrhea (can be benefit in refactory cases), Symptoms associated with carcinoid tumours, To reduce intestinal secretions and vomiting.
The severe or irreversible adverse effects of Sandostatin Inj 0.05mg, which give rise to further complications include Gall stones..Sandostatin Inj 0.05mg produces potentially life-threatening effects which include Hypoglycemia, Hypoglycemia, Hypoglycemia, Hepatic dysfunction, Acute pancreatitis. which are responsible for the discontinuation of Sandostatin Inj 0.05mg therapy.,The symptomatic adverse reactions produced by Sandostatin Inj 0.05mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Flatulence, Loose stools, Anorexia, Abdominal pain, Pain, Local pain, Local reactions, Nausea and vomiting, Tingling, Steatorrhea, Tenderness, Bloating, Stinging.
No data regarding the contra indications of Sandostatin Inj 0.05mg is available.
Sandostatin Inj 0.05mg should be used with caution in patients with kidney disease, diabetes, any other illness or any allergy. Check should be made for gallstone before prolonged therapy and at 6 to 12 months interval during treatment.